Huawei continues to expand its product family. The company, which has had a challenging time in the smartphone market due to the US embargo in recent years, is covering this gap by targeting different ...

AVITA Medical has appointed Cary Vance as Interim CEO following the sudden departure of Jim Corbett, along with a Board reshuffle. The company also announced preliminary third-quarter revenue guidance ...

The FDA is asking for more information regarding Avita's Recell Go device. The Recell Go is a more automated version of an already approved product for Avita. The company said that it is now hoping to ...

On Tuesday, Avita Medical, Inc. (NASDAQ:RCEL) revised its revenue guidance for the fourth quarter and full year of 2024. The regenerative medicine company adjusted its projections due to ...

The Food and Drug Administration signs off on a new wound treatment device by Avita Medical. Tech: Avita's Recell. Valencia-based Avita Medical Inc. has received FDA approval for a version of its ...